[Current advances and the present situation in human brucellosis].
D002002:Brucella / Q000276:immunology / Q000472:pathogenicity; D002006:Brucellosis / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology*; D002908:Chronic Disease; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D012293:Rifampin / Q000627:therapeutic use; D012698:Serologic Tests; D013307:Streptomycin / Q000627:therapeutic use; D013420:Sulfamethoxazole / Q000627:therapeutic use; D013752:Tetracycline / Q000627:therapeutic use; D014295:Trimethoprim / Q000627:therapeutic use
D014295:Trimethoprim; D013752:Tetracycline; D013420:Sulfamethoxazole; D012293:Rifampin; D013307:Streptomycin
Progrès récents et situation actuelle de la brucellose humaine.